Press Release

Thu, 17/09/2020 - 12:00
The Huntington Study Group (“HSG”), a world leader in clinical research for Huntington’s Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R. Hayden, MD, PhD, to conduct PRidopidine Outcome On Function in Huntington’s Disease (PROOF-HD) clinical study. PROOF-HD is a global Phase 3, randomized, double-blind, placebo-controlled, parallel arm, multicenter study evaluating the efficacy and safety of pridopidine in patients with early stage HD.
Mon, 14/09/2020 - 13:00
London, UK, 14th September 2020 / Sciad Newswire / WEP Group Holdings Limited (WEP), a specialist CRO focused on delive
Mon, 14/09/2020 - 09:00
Cambridge, UK, 14th September 2020/ Sciad Newswire / Check4Cancer, the provider of early cancer detection and genetic
Wed, 02/09/2020 - 07:30
Edinburgh, UK, 2nd September 2020 / Sciad Newswire / Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage g
Mon, 03/08/2020 - 10:30
Check4Cancer re-opens ‘SkinCheck’ clinics to provide skin cancer screening during COVID
Mon, 03/08/2020 - 07:00
Amsterdam, the Netherlands, 3rd August 2020 / Sciad Newswire / LUMICKS has entered into a collaboration with
Tue, 21/07/2020 - 07:30
Norwich, UK, 21st July 2020 / Sciad Newswire / The Smarter Food Company has raised £1m in funding to accelerate the devel
Certa Plus
Mon, 20/07/2020 - 07:30
Falmouth, UK, 20th July 2020 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG) announces the launch of its new
Tue, 14/07/2020 - 11:00
San Diego, California and Saffron Walden, UK, 14th July 2020 / Sciad Newswire / Invivoscribe, Inc., an industry pioneer an
Tue, 14/07/2020 - 07:30
Cambridge, UK, 14th July 2020 / Sciad Newswire / Check4Cancer, the reliable and trusted provider of early cancer detec

Pages